The Dental Biomaterials Market is expected to grow at a CAGR of 5.7% during the forecast period 2024-2031
Dental biomaterials are specialized products, either natural or synthetic, that are engineered for use in preventive and restorative dentistry. They serve the purpose of repairing damaged, decayed, or fractured teeth. Known for their efficiency and high success rate in oral treatment and prevention, these biomaterials replace damaged or missing tooth tissues and aid in tissue regeneration. The category of natural biomaterials encompasses enamel, dentin, cementum, bone, and other intraoral tissues. On the other hand, synthetic materials comprise metals, ceramics, polymers, and composite structures.
-
Implantology
-
Periodontology
-
Prosthodontics
-
Orthodontics
-
Others
Dental Biomaterials Market Key Player
Major players are Straumann AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Kuraray Co., Ltd, Medtronic Plc., Henry Schein, Inc., Mitsui Chemicals, Inc., Victrex Plc, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc., Datum Dental Ltd, BEGO Medical GmbH, Cam Bioceramics B.V., Geistlich Pharma AG, BioHorizons IPH, Inc., and Biomatlante.
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian